- Oral antiplatelet agent hypersensitivity and cross-reactivity managed by successful desensitisation
-
Chin N, Rangamuwa , Mariasoosai R, Carnes J, Thien F
- KMID: 2397068
- Asia Pac Allergy.
- 2015 Jan;5(1):51-54.
- doi: 10.5415/apallergy.2015.5.1.51
Oral platelet aggregation inhibitors are widely used for the treatment and prevention of cardiovascular diseases, including coronary stent thrombosis. Premature discontinuation following percutaneous coronary intervention would pose a grave risk... -
- CITED
-
- Close
- SHARE
-
- Close
